This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Is Build-A-Bear (BBW) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Here is how Build-A-Bear (BBW) and CVS Health (CVS) have performed compared to their sector so far this year.
CVS Health (CVS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 2.06% and 0.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's How Investors Can Find Strong Retail and Wholesale Stocks with the Zacks ESP Screener
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
CVS Health (CVS) Stock Moves -0.17%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $108.72 in the latest trading session, marking a -0.17% move from the prior day.
Top Research Reports for Chevron, HSBC & Anthem
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), HSBC Holdings plc (HSBC), and Anthem, Inc. (ANTM).
CVS Health (CVS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Q4 Earnings to Gain From COVID Vaccine Sales
by Zacks Equity Research
CVS Health (CVS) is expected to have seen a significant part of its specialty orders being placed digitally through Q4 months, with growth drivers being COVID testing, vaccines and omni-channel.
AutoZone and National Beverage Corp. highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
AutoZone and National Beverage Corp. highlighted as Zacks Bull and Bear of the Day.
CVS Health (CVS) Hits a 52-Week High: What's Driving It?
by Zacks Equity Research
Strength across the retail segment and growing specialty pharmacy revenues are driving CVS Health's (CVS) top line.
Fortune Brands (FBHS) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Fortune Brands' (FBHS) Q4 earnings are likely to have gained from strength across its plumbing and security businesses. Supply chain constraints and cost inflation might have dragged its margins.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $106.79, moving +1.84% from the previous trading session.
Danaos and Futu Holdings have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Danaos and Futu Holdings have been highlighted as Zacks Bull and Bear of the Day
Momentum in Azure Cloud to Aid Microsoft's (MSFT) Q2 Earnings
by Zacks Equity Research
Microsoft's (MSFT) fiscal second-quarter performance is likely to reflect momentum in the Azure cloud platform due to rapid digital transformation.
CVS Health (CVS) Stock Moves -0.81%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $101.56, moving -0.81% from the previous trading session.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $103.45 in the latest trading session, marking a -1.01% move from the prior day.
Here's Why You Should Hold on to Walgreens Boots (WBA) for Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots' (WBA) robust growth in the International segment and strong first-quarter fiscal 2022 results.
CVS Health (CVS) Stock Moves -0.42%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $105.34 in the latest trading session, marking a -0.42% move from the prior day.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $105.06, moving +0.84% from the previous trading session.
Why CVS Health (CVS) Could Beat Earnings Estimates Again
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain CVS Health (CVS) Stock for Now
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS), owing to consistent improvement in its consumer-centric digital solutions and raised guidance.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $104.16 in the latest trading session, marking a +0.97% move from the prior day.
CVS Health (CVS) Stock Moves -0.02%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $103.68 in the latest trading session, marking a -0.02% move from the prior day.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $101.31, marking a +0.41% move from the previous day.